News Lilly's Lartruvo approved in US for soft tissue sarcoma Eli Lilly’s 'breakthrough' drug for soft tissue sarcoma, Lartruvo, has been approved by the FDA.
News US regulator grants $23 million to rare disease R&D FDA announces 21 rare disease clinical trial research grants.
News Lundbeck epilepsy injection approved in US New carbamazepine formulation when oral dosing not feasible.
News New breakthrough designations for Roche's Alecensa and Actem... Alecensa and Roactemra are breakthroughs, says FDA.
News FDA launches genome sequencing app competition Winning apps will aid in the wider Precision Medicine Initiative.
News GSK to quit Stevenage for new R&D site in Cambridge In a major shake-up of its UK operations, GSK is building a brand new R&D centre in Cambridge and transfer operations there from its Stevenage campus.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
